EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE
Aim: to evaluate the efficacy and tolerability of ornithine aspartate, probiotic Bioflorum Forte and their combination with steatosis and steatohepatitis in patients with alcohol and non-alcoholic fatty liver disease. Materials and methods. An open, randomized, comparative clinical study, whic...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
SINAPS LLC
2016-10-01
|
| Series: | Архивъ внутренней медицины |
| Subjects: | |
| Online Access: | https://www.medarhive.ru/jour/article/view/570 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839572779903483904 |
|---|---|
| author | L. Yu. Ilchenko L. I. Melnikova M. V. Zhuravleva |
| author_facet | L. Yu. Ilchenko L. I. Melnikova M. V. Zhuravleva |
| author_sort | L. Yu. Ilchenko |
| collection | DOAJ |
| description | Aim: to evaluate the efficacy and tolerability of ornithine aspartate, probiotic Bioflorum Forte and their combination with steatosis and steatohepatitis in patients with alcohol and non-alcoholic fatty liver disease. Materials and methods. An open, randomized, comparative clinical study, which included 30 outpatients and inpatients with a diagnosis of steatosis, steatohepatitis. We analyzed the clinical symptoms, functional state of the liver. With the help of questionnaires (Grids LeGo and post intoxication alcohol syndrome) have established the presence of chronic alcohol intoxication. Test transmissions of numbers used to characterize the cognitive function, as well as detection of minimal hepatic encephalopathy. Quality of life was assessed by questionnaire for patients with chronic liver disease — CLDQ (The chronic liver disease questionnaire). The duration of treatment was4 weeks. Results: all three treatment regimens have demonstrated therapeutic efficacy: clinical improvement, recovery of liver function and results in cognitive function. When combined therapy also produced a significant improvement in patients’ quality of life. It is shown that the safety and tolerability of the means employed, adverse events were not reported. Conclusion: the results obtained allow us to recommend the use of ornithine aspartate (Hepa-Merz), both as monotherapy and as part of complex therapy of steatosis, steatohepatitis with probiotic Bioflorum Forte in patients with alcoholic and non-alcoholic fatty liver disease. |
| format | Article |
| id | doaj-art-7211eba3c97c4ec182ccd84d94e6d73d |
| institution | Matheson Library |
| issn | 2226-6704 2411-6564 |
| language | Russian |
| publishDate | 2016-10-01 |
| publisher | SINAPS LLC |
| record_format | Article |
| series | Архивъ внутренней медицины |
| spelling | doaj-art-7211eba3c97c4ec182ccd84d94e6d73d2025-08-04T14:09:45ZrusSINAPS LLCАрхивъ внутренней медицины2226-67042411-65642016-10-0165455210.20514/2226-6704-2016-6-5-45-52548EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASEL. Yu. Ilchenko0L. I. Melnikova1M. V. Zhuravleva2The Central Medical Unit No. 165, MoscowThe Central Medical Unit No. 165, Moscow; Pirogov Russian National Research Medical University, MoscowFirst Moscow State Medical University named after I.M. Sechenov, MoscowAim: to evaluate the efficacy and tolerability of ornithine aspartate, probiotic Bioflorum Forte and their combination with steatosis and steatohepatitis in patients with alcohol and non-alcoholic fatty liver disease. Materials and methods. An open, randomized, comparative clinical study, which included 30 outpatients and inpatients with a diagnosis of steatosis, steatohepatitis. We analyzed the clinical symptoms, functional state of the liver. With the help of questionnaires (Grids LeGo and post intoxication alcohol syndrome) have established the presence of chronic alcohol intoxication. Test transmissions of numbers used to characterize the cognitive function, as well as detection of minimal hepatic encephalopathy. Quality of life was assessed by questionnaire for patients with chronic liver disease — CLDQ (The chronic liver disease questionnaire). The duration of treatment was4 weeks. Results: all three treatment regimens have demonstrated therapeutic efficacy: clinical improvement, recovery of liver function and results in cognitive function. When combined therapy also produced a significant improvement in patients’ quality of life. It is shown that the safety and tolerability of the means employed, adverse events were not reported. Conclusion: the results obtained allow us to recommend the use of ornithine aspartate (Hepa-Merz), both as monotherapy and as part of complex therapy of steatosis, steatohepatitis with probiotic Bioflorum Forte in patients with alcoholic and non-alcoholic fatty liver disease.https://www.medarhive.ru/jour/article/view/570steatosissteatohepatitisornithine aspartateprobiotic bioflorum forte |
| spellingShingle | L. Yu. Ilchenko L. I. Melnikova M. V. Zhuravleva EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE Архивъ внутренней медицины steatosis steatohepatitis ornithine aspartate probiotic bioflorum forte |
| title | EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE |
| title_full | EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE |
| title_fullStr | EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE |
| title_full_unstemmed | EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE |
| title_short | EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE |
| title_sort | experience of ornithine aspartate hepa merz and probiotics bioflorum forte in the treatment of non severe forms of alcoholic and non alcoholic fatty liver disease |
| topic | steatosis steatohepatitis ornithine aspartate probiotic bioflorum forte |
| url | https://www.medarhive.ru/jour/article/view/570 |
| work_keys_str_mv | AT lyuilchenko experienceofornithineaspartatehepamerzandprobioticsbioflorumforteinthetreatmentofnonsevereformsofalcoholicandnonalcoholicfattyliverdisease AT limelnikova experienceofornithineaspartatehepamerzandprobioticsbioflorumforteinthetreatmentofnonsevereformsofalcoholicandnonalcoholicfattyliverdisease AT mvzhuravleva experienceofornithineaspartatehepamerzandprobioticsbioflorumforteinthetreatmentofnonsevereformsofalcoholicandnonalcoholicfattyliverdisease |